Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 134 clinical trials
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT. 5-fraction SABR is a feasible, well-tolerated, …

adenocarcinoma
adenocarcinoma of prostate
stereotactic body radiation therapy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Patients with unequivocal recurrence (first or greater) established by MRI and meeting inclusion and exclusion criteria, will be eligible for OKN-007 treatment on this protocol.

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Minocycline in MS: Confirmation of Benefit

Trial participants will include men and women, aged 18-60 years who have had a first demyelinating event within the previous 180 days and who have brain magnetic resonance imaging (MRI) with at least two brain T2 lesions which are at least 3 mm in diameter, and at least one of …

brain lesion
health screening
MRI
minocycline
demyelination
  • 0 views
  • 19 Feb, 2024
  • 1 location
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

The researchers are doing this study to find out whether the researchers can combine information provided by PET/MRI scans with information from tests on blood and tissue samples to develop a very detailed description (profile) of high-grade serous ovarian carcinoma (HGSOC), which could improve our ability to treat this disease.

ovarian cancer
carcinoma
cancer
ovarian carcinoma
  • 0 views
  • 19 Feb, 2024
  • 1 location
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia (FORTUNE)

In this study we plan to determine whether Diroximel Fumarate (DRF) (currently a treatment for a brain disorder called multiple sclerosis) can increase GSH in the brain of patients with schizophrenia using a brain scan (MRI) and explore whether changes in GSH are related to other brain measures (measured with …

  • 0 views
  • 06 May, 2025
  • 1 location
Altered Tumor Oxygenation by Metformin a Potential Step in Overcoming Radiotherapy Resistance in LACC

Tumor oxygenation will be evaluated by gene signatures and MRI- parameters.

cisplatin
neutrophil count
serum pregnancy test
squamous cell carcinoma
diabetes
  • 0 views
  • 19 Feb, 2024
  • 1 location
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

More, this accelerator allows a re-optimization of the initial dosimetric plan to the anatomical changes of the day to allow an MRI guided adaptive radiotherapy.

liver cancer
skin cancer
cancer
hepatitis
metastasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
PET Imaging of Cyclooxygenases in Dementia

Their heart function will be measured. Participants will have a magnetic resonance imaging (MRI) scan. The MRI scanner is a metal tube surrounded by a strong magnetic field. Participants will lie on a table that slides in and out of the tube.

cognitive impairment
alzheimer's disease
positron emission tomography
huntington's chorea
anxiety
  • 0 views
  • 19 Feb, 2024
  • 1 location
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

They will have a computed tomography (CT) scan or magnetic resonance imaging (MRI). A CT is a series of X-rays of the body. An MRI uses magnets and radio waves to take pictures of the body. Adult participants may have tumor biopsies.

neutrophil count
electroencephalogram
primary tumor
cancer
blood tests
  • 0 views
  • 24 Nov, 2025
  • 1 location
Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Participants will undergo history-taking, clinical examination, laboratory investigations, Triphasic CT abdomen with contrast or MRI (for evaluation of tumor site, size and number), abdominal ultrasonography, and upper endoscopy (within 6 months before beginning of systemic therapy and followed up after 3, 6, 9, and 12 months).

  • 0 views
  • 09 May, 2025